ACQUIRED · 2020
Who Acquired Marley Drug, Inc?
Medicure Inc. · $6.3M· 3.7× EBITDA
The acquisition
Marley Drug, Inc was acquired by Medicure Inc. in 2020 for $6.3M. The deal was priced at 3.7× EBITDA / 0.90× revenue.
Marley Drug, Inc at time of acquisition
Revenue
$7.0M
EBITDA
$1.7M
Deal value
$6.3M
EV / EBITDA
3.7×
Other acquisitions by Medicure Inc.
Recent transactions by the same buyer — useful for understanding their playbook and what they typically pay.
- West Olympia Pharmacy Inc. · 2025 · $1.0M · 3.0× EBITDA
Similar pharmacy acquisitions
- University Compounding Pharmacy · acquired by Fagron in 2026 · $41.5M
- Choice Specialty Pharmacy Group · acquired by Better Choice Company, Inc. in 2025 · $28.0M
- Horizon Infusions · acquired by Rubicon in 2025 · $130.0M
- KabaFusion · acquired by Nautic Partners in 2025 · $2.20B
- Soleo Health · acquired by Court Square Capital and WindRose Health in 2025 · $1.10B
Run a valuation for a similar pharmacy business
Three fields, instant range, backed by 25,592 real M&A transactions including this one.
Open the pharmacy calculator →More on pharmacy valuations
- Value a medical practice
- Value a dental practice
- Value a veterinary practice
- Pharmacy valuation calculator· head-term variant
- Pharmacy median multiples· real-deal benchmarks
- How to value a pharmacy· long-form guide
Sourced from Press releases. Full deal page.
Citation: ExitValue.ai. (2020). Marley Drug, Inc acquired by Medicure Inc.. https://exitvalue.ai/acquired/marley-drug-inc